share_log

Veru Shares Are Trading Higher Following Publication of Briefing Documents Ahead of the Nov. 9 FDA Adcom Meeting for Its COVID-19 Treatment Candidate.

Benzinga ·  Nov 7, 2022 10:31
Veru shares are trading higher following publication of briefing documents ahead of the Nov. 9 FDA Adcom meeting for its COVID-19 treatment candidate.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment